EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Comparative Study on the Complexation of the Anticancer Iron Chelator VLX600 with Essential Metal Ions

Vivien Pósa, Anja Federa, Klaudia Cseh, Dominik Wenisch, Gabriella Spengler, Nóra V May, Norbert Lihi iD, Gergely F Samu iD, Michael A Jakupec iD, Bernhard K Keppler, Christian R Kowol iD, Éva A Enyedy iD

Inorganic Chemistry · 2024

DOI: 10.1021/acs.inorgchem.3c03259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Vivien Pósa und 11 weiteren Autor:innen. Beteiligte Einrichtung: MTA-SZTE Lendület Functional Metal Complexes Research Group, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary. Hauptthemen laut MEDLINE: Ferric Compounds, Coordination Complexes, Hydrazones, Triazoles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, National Research, Development and Innovation Office, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As cancer cells exhibit an increased uptake of iron, targeting the interaction with iron has become a straightforward strategy in the fight against cancer. This work comprehensively characterizes the chemical properties of 6-methyl-3-{(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}-5H-[1,2,4]triazino[5,6-b]indole (VLX600), a clinically investigated iron chelator, in solution. Its protonation processes, lipophilicity, and membrane permeability as well as its complexation with essential metal ions were investigated using UV-visible, electron paramagnetic resonance, and NMR spectroscopic and computational methods. Formation constants revealed the following order of metal binding affinity at pH 7.4: Cu(II) > Fe(II) > Zn(II). The structures of VLX600 (denoted as HL) and the coordination modes in its metal complexes [Cu(II)(LH)Cl2], [Cu(II)(L)(CH3OH)Cl], [Zn(II)(LH)Cl2], and [Fe(II)(LH)2](NO3)2 were elucidated by single-crystal X-ray diffraction. Redox properties of the iron complexes characterized by cyclic voltammetry showed strong preference of VLX600 toward Fe(II) over Fe(III). In vitro cytotoxicity of VLX600 was determined in six different human cancer cell lines, with IC50 values ranging from 0.039 to 0.51 μM. Premixing VLX600 with Fe(III), Zn(II), and Cu(II) salts in stoichiometric ratios had a rather little effect overall, thus neither potentiating nor abolishing cytotoxicity. Together, although clinically investigated as an iron chelator, this is the first comprehensive solution study of VLX600 and its interaction with physiologically essential metal ions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ferric CompoundsCoordination ComplexesHydrazonesTriazolesHumansCopperMetalsIronIonsIron Chelating AgentsFerrous Compounds

Substanzen

VLX600Ferric CompoundsCopperMetalsIronIonsCoordination ComplexesIron Chelating AgentsFerrous CompoundsHydrazones

Autor:innen und Institutionen

  • MTA-SZTE Lendület Functional Metal Complexes Research Group, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary.
  • Department of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary.
  • Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 42, A-1090 Vienna, Austria.
  • Research Cluster "Translational Cancer Therapy Research", Waehringer Strasse 42, A-1090 Vienna, Austria.
  • Department of Medical Microbiology, Albert Szent-Györgyi Health Center and Albert Szent-Györgyi Medical School, University of Szeged, Semmelweis utca 6, H-6725 Szeged, Hungary.
  • Centre for Structural Science, Research Centre for Natural Sciences, Hungarian Research Network (HUN-REN), Magyar tudósok körútja 2, H-1117 Budapest, Hungary.

ORCID-Profile: Norbert Lihi, Gergely F Samu, Michael A Jakupec, Christian R Kowol, Éva A Enyedy

Förderung

  • Austrian Science Fund FWF
  • National Research, Development and Innovation Office
  • Austrian Science Fund
  • New National Excellence Program
  • HUN-REN Hungarian Research Network

Zitieren

APA

Pósa, V., Federa, A., Cseh, K., Wenisch, D., Spengler, G., May, N. V., Lihi, N., Samu, G. F., Jakupec, M. A., Keppler, B. K., Kowol, C. R., & Enyedy, É. A. (2024). A Comparative Study on the Complexation of the Anticancer Iron Chelator VLX600 with Essential Metal Ions. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.3c03259

Vancouver

Pósa V, Federa A, Cseh K, Wenisch D, Spengler G, May NV, et al. A Comparative Study on the Complexation of the Anticancer Iron Chelator VLX600 with Essential Metal Ions. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.3c03259

BibTeX
@article{Psa2024,
  author = {Pósa, Vivien and Federa, Anja and Cseh, Klaudia and Wenisch, Dominik and Spengler, Gabriella and May, Nóra V and Lihi, Norbert and Samu, Gergely F and Jakupec, Michael A and Keppler, Bernhard K and Kowol, Christian R and Enyedy, Éva A},
  title = {A Comparative Study on the Complexation of the Anticancer Iron Chelator VLX600 with Essential Metal Ions},
  journal = {Inorganic Chemistry},
  year = {2024},
  doi = {10.1021/acs.inorgchem.3c03259}
}
Kostenlos starten →